We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
3.00 | 0.18% | 1,673.00 | 1,674.00 | 1,675.00 | 1,679.50 | 1,658.50 | 1,661.50 | 7,034,492 | 16:35:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.99 | 68.96B |
TIDMGSK
RNS Number : 3438U
GSK PLC
27 March 2023
GSK plc
(the 'Company')
Publication of Notice of Annual General Meeting 2023
The Company has today published on its website ( www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/ ) the Notice of Annual General Meeting ('AGM') 2023 (the '2023 AGM Notice'), which will be distributed to shareholders shortly.
The Company's AGM will be held on Wednesday 3 May 2023 at 2.30pm at the Sofitel London Heathrow, Terminal 5, London Heathrow Airport, TW6 2GD and will also be broadcast live for shareholders to join electronically. Full details of how to join the meeting either in person or electronically are contained in the 2023 AGM Notice and AGM Guide.
In compliance with Listing Rule 9.6.1R of the UK Financial Conduct Authority, the 2023 AGM Notice and Proxy Form for the AGM will be submitted to the UK Listing Authority and will, in due course, be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
V A Whyte
Company Secretary
27 March 2023
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NOADZGZFMNNGFZM
(END) Dow Jones Newswires
March 27, 2023 08:00 ET (12:00 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions